LEXICON PHARMACEUTICALS, INC. Increase (Decrease) in Inventories
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Increase (Decrease) in Inventories of $915.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-06
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $920.00K.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$5.00K.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $123.00K.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$10.00K, a 119.61% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2025 was $50.00K.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2024 was -$150.00K, a 139.37% decline from fiscal 2023.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2023 was $381.00K.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2022 was $0.00.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $920.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $915.00K 10-Q · filed 2026-08-06 | $1.04M derived: sum of 3 quarters · filed 2026-08-06 | $1.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$5.00K 10-Q · filed 2026-05-07 | $118.00K derived: sum of 2 quarters · filed 2026-05-07 | $108.00K derived: sum of 3 quarters · filed 2026-05-07 | $75.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $113.00K derived: sum of 2 quarters · filed 2026-03-05 | $80.00K derived: sum of 3 quarters · filed 2026-08-06 | $50.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$43.00K derived: sum of 2 quarters · filed 2026-08-06 | -$73.00K 10-Q · filed 2025-11-06 | -$478.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$63.00K 10-Q · filed 2026-08-06 | -$468.00K derived: sum of 3 quarters · filed 2026-08-06 | -$417.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$30.00K 10-Q · filed 2026-05-07 | -$435.00K derived: sum of 2 quarters · filed 2026-05-07 | -$384.00K derived: sum of 3 quarters · filed 2026-05-07 | -$313.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$405.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$354.00K derived: sum of 2 quarters · filed 2026-03-05 | -$283.00K derived: sum of 3 quarters · filed 2026-03-05 | -$150.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $122.00K derived: sum of 2 quarters · filed 2025-11-06 | $255.00K 10-Q · filed 2025-11-06 | $300.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | $71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $204.00K 10-Q · filed 2025-08-06 | $249.00K derived: sum of 3 quarters · filed 2026-03-05 | $413.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | $133.00K 10-Q · filed 2025-05-14 | $178.00K derived: sum of 2 quarters · filed 2026-03-05 | $342.00K derived: sum of 3 quarters · filed 2026-03-05 | $514.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $209.00K derived: sum of 2 quarters · filed 2026-03-05 | $381.00K derived: sum of 3 quarters · filed 2026-03-05 | $381.00K 10-K · filed 2026-03-05 |
| 2023-09-30 | $164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $336.00K derived: sum of 2 quarters · filed 2024-11-13 | $336.00K 10-Q · filed 2024-11-13 | $336.00K derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-06-30 | $172.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $172.00K 10-Q · filed 2024-08-02 | $172.00K derived: sum of 3 quarters · filed 2025-03-07 | $172.00K derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | $0.00 derived: sum of 2 quarters · filed 2025-03-07 | $0.00 derived: sum of 3 quarters · filed 2025-03-07 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $0.00 derived: sum of 2 quarters · filed 2025-03-07 | $0.00 10-K · filed 2025-03-07 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-04 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $0.00 derived: sum of 2 quarters · filed 2024-03-25 | $0.00 derived: sum of 3 quarters · filed 2024-03-25 | $0.00 10-K · filed 2024-03-25 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | $0.00 derived: sum of 3 quarters · filed 2023-03-03 | -$91.00K derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 | $0.00 derived: sum of 2 quarters · filed 2023-03-03 | -$91.00K derived: sum of 3 quarters · filed 2023-03-03 | -$249.00K derived: sum of 4 quarters · filed 2023-03-03 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | -$91.00K derived: sum of 2 quarters · filed 2023-03-03 | -$249.00K derived: sum of 3 quarters · filed 2023-03-03 | -$345.00K 10-K · filed 2023-03-03 |
| 2020-09-30 | -$91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$249.00K derived: sum of 2 quarters · filed 2021-11-09 | -$345.00K 10-Q · filed 2021-11-09 | -$578.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | -$158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$254.00K 10-Q · filed 2021-08-06 | -$487.00K derived: sum of 3 quarters · filed 2022-03-10 | -$288.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | -$96.00K 10-Q · filed 2021-05-06 | -$329.00K derived: sum of 2 quarters · filed 2022-03-10 | -$130.00K derived: sum of 3 quarters · filed 2022-03-10 | -$459.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | -$233.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$34.00K derived: sum of 2 quarters · filed 2022-03-10 | -$363.00K derived: sum of 3 quarters · filed 2022-03-10 | -$437.00K 10-K · filed 2022-03-10 |
| 2019-09-30 | $199.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | -$130.00K derived: sum of 2 quarters · filed 2020-10-30 | -$204.00K 10-Q · filed 2020-10-30 | -$279.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | -$329.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$403.00K 10-Q · filed 2020-07-29 | -$478.00K derived: sum of 3 quarters · filed 2021-03-12 | $2.13M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | -$74.00K 10-Q · filed 2020-04-27 | -$149.00K derived: sum of 2 quarters · filed 2021-03-12 | $2.46M derived: sum of 3 quarters · filed 2021-03-12 | $2.49M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | -$75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $2.54M derived: sum of 2 quarters · filed 2021-03-12 | $2.57M derived: sum of 3 quarters · filed 2021-03-12 | $2.73M 10-K · filed 2021-03-12 |
| 2018-09-30 | $2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.64M derived: sum of 2 quarters · filed 2019-11-07 | $2.81M 10-Q · filed 2019-11-07 | $2.61M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $194.00K 10-Q · filed 2019-08-01 | -$7.00K derived: sum of 3 quarters · filed 2020-03-12 | $1.33M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $164.00K 10-Q · filed 2019-05-01 | -$37.00K derived: sum of 2 quarters · filed 2020-03-12 | $1.30M derived: sum of 3 quarters · filed 2020-03-12 | $1.88M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | -$201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.14M derived: sum of 2 quarters · filed 2020-03-12 | $1.71M derived: sum of 3 quarters · filed 2020-03-12 | $1.95M 10-K · filed 2020-03-12 |
| 2017-09-30 | $1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.91M derived: sum of 2 quarters · filed 2018-11-01 | $2.15M 10-Q · filed 2018-11-01 | $2.15M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $575.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | $811.00K 10-Q · filed 2018-07-30 | $811.00K derived: sum of 3 quarters · filed 2019-03-15 | $811.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $236.00K 10-Q · filed 2018-05-03 | $236.00K derived: sum of 2 quarters · filed 2019-03-15 | $236.00K derived: sum of 3 quarters · filed 2019-03-15 | $236.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $0.00 derived: sum of 2 quarters · filed 2019-03-15 | $0.00 derived: sum of 3 quarters · filed 2019-03-15 | $0.00 10-K · filed 2019-03-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $0.00 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $0.00 10-Q · filed 2017-08-01 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |